|
시장보고서
상품코드
2121022
포유류 유래 단백질 시장 규모, 점유율 및 성장 분석 : 단백질 유형별, 원료별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Mammalian Derived Proteins Market Size, Share, and Growth Analysis, By Protein Type (Growth Factors, Cytokines), By Source (Human, Bovine), By Application, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 포유류 유래 단백질 시장 규모는 2024년에 21억 8,000만 달러로 평가되며, 2025년 23억 7,000만 달러에서 2033년까지 46억 2,000만 달러로 확대하며, 예측 기간(2026-2033년)에 CAGR 8.7%로 성장할 것으로 전망되고 있습니다.
포유류 유래 단백질의 글로벌 시장은 소 혈청 알부민, 콜라겐, 면역글로불린 등 가축 유래 단백질이 특징이며, 이들은 인간의 생화학적 특성과 높은 적합성을 바탕으로 의약품, 진단약, 세포배양 배지에서 매우 중요한 역할을 수행하고 있습니다. 이러한 적합성 덕분에 재조합 단백질에 비해 효능이 향상되고 면역원성이 감소하는 효과가 나타납니다. 과거에는 학술 분야에 국한되었던 이 시장은 정제 기술의 혁신과 바이오의약품에 대한 수요 확대에 힘입어 크게 성장하고 있습니다. 바이오의약품 개발이 급속히 증가함에 따라 무혈청이며 동물과의 적합성이 높은 배지의 필요성이 높아지고 있으며, 그 결과 콜라겐이나 알부민과 같은 주요 단백질의 생산이 확대되고 있습니다. 이로 인해 제조 비용이 절감되고, 암 치료 제품의 시장 출시가 가속화되며, 재생의료 분야에 대한 투자가 촉진되어 시장의 성장이 더욱 가속화되고 있습니다.
세계 포유류 유래 단백질 시장의 성장 요인
기본적인 영양 섭취를 넘어 건강상 이점을 제공하는 단백질 원료에 대한 소비자의 수요가 증가하고 있습니다. 소비자들은 근육 회복을 돕고, 면역 기능을 강화하며, 포만감을 높여주는 단백질을 찾고 있습니다. 포괄적인 아미노산 프로필과 생리활성 펩티드로 알려진 포유류 유래 단백질은 이러한 소비자의 기대에 부응하며, 스낵바, 유제품 대체품, 영양 강화 음료 등 다양한 제품에 점점 더 많이 활용되고 있습니다. 이러한 추세는 제품 혁신을 촉진하고 유통망을 확대하며, 궁극적으로 각 브랜드가 이러한 단백질의 부가가치와 기능적 이점을 활용하여 치열한 시장에서 차별화를 꾀함으로써 매출 성장을 촉진하게 될 것입니다.
전 세계 포유류 유래 단백질 시장의 제약 요인
전 세계 포유류 유래 단백질 시장은 주요 지역의 당국이 시행하는 엄격한 규제로 인해 큰 제약을 받고 있습니다. 이러한 규제는 공중 보건 보호와 윤리 기준 유지를 목적으로 하며, 안전성, 표시, 동물 복지에 중점을 두고 있습니다. 제조업체는 광범위한 검증 시험, 추적성을 위한 문서화, 그리고 정기적인 감사 실시에 막대한 시간과 자원을 투입해야 합니다. 이로 인해 제품을 시장에 출시하는 데 걸리는 시간이 길어질 뿐만 아니라 업무의 복잡성도 가중됩니다. 또한 규제 변경에 따른 불확실성은 기업이 성장 기회보다 규정 준수를 우선시하게 만들어 신제품 출시를 저해하고, 잠재적인 용도를 제한하며, 궁극적으로 시장 성장을 둔화시킬 가능성이 있습니다.
세계 포유류 유래 단백질 시장의 동향
전 세계 포유류 유래 단백질 시장은 지속가능한 단백질 혁신에 대한 강력한 추세에 힘입어 큰 변화를 겪고 있습니다. 각 제조사는 친환경 조달 전략을 점점 더 많이 채택하며 온실가스 배출 감축에 주력하고 있습니다. 이러한 상황에서 첨단 육종 기술, 폐기물 최소화, 순환형 바이오 경제 모델에 대한 투자가 확산되고 있으며, 기업은 제품별로 더 큰 가치를 창출할 수 있게 되었습니다. 이러한 움직임은 주로 책임감 있게 조달된 동물성 원료에 대한 소비자 수요 증가와 지속가능성 목표를 향한 기업의 노력에 힘입어 가속화되고 있습니다. 공급망의 투명성이 높아짐에 따라 포유류 유래 단백질 생산에서 지속가능한 노력을 우선시하는 기업은 경쟁적 차별화 측면에서 선도적인 위치를 확립하고, 이해관계자들로부터의 신뢰를 더욱 공고히 하고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
개요
시장 역학과 전망
주요 시장 인사이트
세계의 포유류 유래 단백질 시장 규모 : 단백질 유형별
세계의 포유류 유래 단백질 시장 규모 : 소스별
세계의 포유류 유래 단백질 시장 규모 : 용도별
세계의 포유류 유래 단백질 시장 규모 : 최종사용자별
세계의 포유류 유래 단백질 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSA 26.08.31Global Mammalian Derived Proteins Market size was valued at USD 2.18 Billion in 2024 and is poised to grow from USD 2.37 Billion in 2025 to USD 4.62 Billion by 2033, growing at a CAGR of 8.7% during the forecast period (2026-2033).
The global market for mammalian derived proteins is characterized by proteins sourced from livestock like bovine serum albumin, collagen, and immunoglobulins, which play pivotal roles in pharmaceuticals, diagnostics, and cell-culture media due to their high compatibility with human biochemistry. This compatibility results in enhanced efficacy and reduced immunogenicity compared to recombinant proteins. The market, once constrained to academic settings, has expanded significantly, driven by innovations in purification technologies and a growing demand for biologics. The rapid increase in biopharmaceutical developments has heightened the need for serum-free, animal-compatible media, thereby boosting production of key proteins like collagen and albumin. This, in turn, lowers manufacturing costs, accelerates market entry for oncology products, and fosters investment in regenerative medicine applications, further propelling market growth.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mammalian Derived Proteins market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Mammalian Derived Proteins Market Segments Analysis
Global mammalian derived proteins market is segmented by protein type, source, application, end user and region. Based on protein type, the market is segmented into growth factors, cytokines, enzymes and structural proteins. Based on source, the market is segmented into human, bovine and murine. Based on application, the market is segmented into cell culture, drug discovery, regenerative medicine and biopharmaceutical manufacturing. Based on end user, the market is segmented into biotechnology companies, pharmaceutical companies and research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Mammalian Derived Proteins Market
The demand for protein ingredients offering health advantages that extend beyond basic nutrition is on the rise among consumers. They are looking for proteins that support muscle recovery, boost immune function, and promote satiety. Mammalian derived proteins, recognized for their comprehensive amino acid profiles and bioactive peptides, meet these consumer expectations and are increasingly being integrated into various products, including snack bars, dairy substitutes, and fortified beverages. This trend fosters product innovation and broadens distribution networks, ultimately driving revenue growth as brands capitalize on the perceived added value and functional benefits of these proteins to stand out in a competitive marketplace.
Restraints in the Global Mammalian Derived Proteins Market
The Global Mammalian Derived Proteins market faces significant restraints due to the stringent regulations imposed by authorities in key regions. These regulations focus on safety, labeling, and animal welfare, all intended to safeguard public health and uphold ethical standards. Manufacturers must invest considerable time and resources into extensive validation studies, documentation for traceability, and undergoing routine audits. This not only extends the time required to bring products to market but also increases operational complexities. Additionally, the uncertainty surrounding changing regulations may hinder the launch of new products and restrict potential applications, as businesses prioritize compliance over growth opportunities, ultimately slowing market progress.
Market Trends of the Global Mammalian Derived Proteins Market
The global mammalian derived proteins market is undergoing a significant transformation driven by a robust trend towards sustainable protein innovation. Manufacturers are increasingly adopting environmentally friendly sourcing strategies and focusing on reducing their greenhouse gas emissions. In this context, investments in advanced breeding techniques, waste minimization, and circular bio-economy models are becoming prevalent, allowing companies to derive greater value from by-products. This movement is largely motivated by rising consumer demand for responsibly sourced animal-derived ingredients and corporate commitments to sustainability goals. As transparency in supply chains improves, firms that prioritize sustainable practices in mammalian protein production are establishing themselves as leaders in competitive differentiation and fostering stronger stakeholder trust.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Mammalian Derived Proteins Market Size by Protein Type & CAGR (2026-2033)
- Market Overview
- Growth Factors
- Cytokines
- Enzymes
- Structural Proteins
Global Mammalian Derived Proteins Market Size by Source & CAGR (2026-2033)
- Market Overview
- Human
- Bovine
- Murine
Global Mammalian Derived Proteins Market Size by Application & CAGR (2026-2033)
- Market Overview
- Cell Culture
- Drug Discovery
- Regenerative Medicine
- Biopharmaceutical Manufacturing
Global Mammalian Derived Proteins Market Size by End User & CAGR (2026-2033)
- Market Overview
- Biotechnology Companies
- Pharmaceutical Companies
- Research Institutes
Global Mammalian Derived Proteins Market Size & CAGR (2026-2033)
- North America (Protein Type, Source, Application, End User)
- US
- Canada
- Europe (Protein Type, Source, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Protein Type, Source, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Protein Type, Source, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Protein Type, Source, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lonza Group AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Techne Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- FUJIFILM Irvine Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- STEMCELL Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Corning Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CellGenix GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PromoCell GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Proteintech Group, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abcam plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sino Biological, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GenScript Biotech Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Creative BioMart
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ACROBiosystems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OriGene Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PeproTech, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Miltenyi Biotec B.V. & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cyagen Biosciences Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
